Internal Medicine, Rheumatology · Dallas, TX
NPI
1154351054
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3600 Gaston Ave Ste 100
Dallas, TX, 75246
Phone (214) 823-6503
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
89,616 services
Medicare patients, 2024
556
Average age 74
Drug cost, 2024
$3.4M
10,835 prescriptions
Company payments, 2025
$31K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Iftikhar A Chowdhry was code J0897 (injection, denosumab, 1 mg), 11,160 times for 120 patients. In total Iftikhar A Chowdhry billed 89,616 services in 91 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 11,160 | 120 | $20.39 | $228K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 7,096 | 96 | $0.10 | $692 |
| J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2,160 | 35 | $6.98 | $15K |
| 99214 Office E&M - Established | Office | 1,022 | 431 | $91.46 | $93K |
| 99215 Office E&M - Established | Office | 809 | 349 | $133.76 | $108K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 796 | 376 | $12.81 | $10K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 678 | 17 | $0.22 | $151 |
| 80053 Clinical Chemistry | Office | 601 | 333 | $10.27 | $6,174 |
| 85651 Clinical Chemistry | Office | 600 | 345 | $4.15 | $2,489 |
| 85025 Blood Count | Office | 443 | 265 | $7.55 | $3,344 |
| 36415 Venipuncture Blood Collection | Office | 322 | 216 | $5.66 | $1,824 |
| 82784 Immunoassay | Office | 314 | 101 | $9.03 | $2,834 |
| 96401 Chemotherapy Administration | Office | 309 | 135 | $56.69 | $18K |
| 81003 Clinical Chemistry | Office | 293 | 211 | $2.20 | $645 |
| 82728 Clinical Chemistry | Office | 246 | 211 | $13.26 | $3,261 |
By year: 2022 $1.1M for 90,014 services; 2023 $1.2M for 103,469 services; 2024 $1.1M for 89,616 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 601 | 333 | $10.27 | $6,174 |
| 85651 Clinical Chemistry | 600 | 345 | $4.15 | $2,489 |
| 85025 Blood Count | 443 | 265 | $7.55 | $3,344 |
| 36415 Venipuncture Blood Collection | 322 | 216 | $5.66 | $1,824 |
| 82784 Immunoassay | 314 | 101 | $9.03 | $2,834 |
| 81003 Clinical Chemistry | 293 | 211 | $2.20 | $645 |
| 82728 Clinical Chemistry | 246 | 211 | $13.26 | $3,261 |
| 82306 Clinical Chemistry | 237 | 214 | $28.90 | $6,848 |
| 84443 Clinical Chemistry | 213 | 180 | $16.39 | $3,492 |
| 82550 Clinical Chemistry | 201 | 176 | $6.35 | $1,277 |
Medicare prescription drug claims, 2024
In 2024, the drug Iftikhar A Chowdhry prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,252 prescriptions and refills. In total Iftikhar A Chowdhry wrote 10,835 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,252 | 2,068 | 294 | $41K |
| Duloxetine Hcl Generic | 1,138 | 1,671 | 248 | $27K |
| Prednisone Generic | 853 | 1,084 | 201 | $4,494 |
| Gabapentin Generic | 694 | 949 | 166 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 549 | 552 | 114 | $15K |
| Tramadol Hcl Generic | 414 | 431 | 129 | $3,100 |
| Pregabalin Generic | 338 | 476 | 73 | $9,878 |
| Celecoxib Generic | 329 | 473 | 73 | $6,649 |
| Methotrexate Methotrexate Sodium | 284 | 514 | 72 | $6,876 |
| Tizanidine Hcl Generic | 239 | 317 | 60 | $2,749 |
| Leflunomide Generic | 209 | 386 | 56 | $9,281 |
| Colchicine Generic | 189 | 304 | 56 | $16K |
| Meloxicam Generic | 186 | 280 | 43 | $897 |
| Trazodone Hcl Generic | 173 | 265 | 36 | $1,256 |
| Diclofenac Sodium Generic | 172 | 240 | 73 | $14K |
Brand drugs: - claims; generic drugs: 10,048 claims; opioid claims: 1,121.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Iftikhar A Chowdhry $31K ($31K in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 84 | $21K |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $6,132 |
| Amgen Inc. AMGN | 54 | $879 |
| Medtronic, Inc. MDT | 1 | $453 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $393 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $261 |
| Mallinckrodt Hospital Products Inc. | 12 | $254 |
| UCB, Inc. UCB.BR | 9 | $214 |
| Genzyme Corporation SNY | 8 | $195 |
| TerSera Therapeutics LLC | 13 | $179 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.